Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for PPHN
NCT00409526Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Dec 2006
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, open-label trial of iloprost in persistent pulmonary hypertension of the newborn (PPHN) (2 arms), sponsored by University of Chicago. Primary endpoints: Oxygenation Index at 3 hours and Partial Pressure of Oxygen at 3 hours. Started Dec 2006; status: terminated.
02
Drugs
iloprost
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT00409526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409526.